Nathan Dawkins

Dr. Nathan Dawkins

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2022 in European Heart Journal
Verified
Journal Article
Closed access
PDF file
PDPaddy C Dempsey
Paddy C Dempsey
ARAlex Rowlands
Alex Rowlands
TSTessa Strain
Tessa Strain
FZFrancesco Zaccardi
Francesco Zaccardi
NDNathan Dawkins
Nathan Dawkins
TYTom Yates
Tom Yates
Aims: The interplay between physical activity (PA) volume and intensity is poorly understood in relation to cardiovascular disease (CVD) risk. This study aimed to investigate the role of PA intensity, over and above volume, in relation to incident CVD. Methods and results: Data were from 88 412 UK Biobank middle-aged adults (58% women) without prevalent CVD who wore accelerometers on their dominant wrist for 7 days, from which we estimated total PA energy expenditure (PAEE) using population-specific validation. Cox proportional hazards regressions modelled associations between PAEE (kJ/kg/day) and PA intensity (%MVPA; the fraction of PAEE accumulated from moderate-to-vigorous-intensity PA) with incident CVD (ischaemic heart disease or cerebrovascular disease), adjusted for potential confounders. There were 4068 CVD events during 584 568 person-years of follow-up (median 6.8 years). Higher PAEE and higher %MVPA (adjusted for PAEE) were associated with lower rates of incident CVD. In interaction analyses, CVD rates were 14% (95% confidence interval: 5–23%) lower when MVPA accounted for 20% rather than 10% of 15 kJ/kg/d PAEE; equivalent to converting a 14 min stroll into a brisk 7 min walk. CVD rates did not differ significantly between values of PAEE when the %MVPA was fixed at 10%. However, the lowest CVD rates were observed for combinations of both higher PAEE and %MVPA. Conclusion: Reductions in CVD risk may be achievable through higher PA volume and intensity, with the role of moderately intense PA appearing particularly important. This supports multiple approaches or strategies to PA participation, some of which may be more practical or appealing to different individuals.

5 December 2019 in Sports Medicine - Open
Verified
Journal Article
Open access
PDF file
ARAlex Rowlands
Alex Rowlands
NDNathan Dawkins
Nathan Dawkins
BMBen Maylor
Ben Maylor
CECharlotte Edwardson
Charlotte Edwardson
Stuart FaircloughStuart Fairclough
Stuart Fairclough
TYThomas Yates
Thomas Yates
The lack of consensus on meaningful and interpretable physical activity outcomes from accelerometer data hampers comparison across studies. Cut-point analyses are simple to apply and easy to interpret but can lead to results that are not comparable. We propose that the optimal accelerometer metrics for data analysis are not the same as the optimal metrics for translation. Ideally, analytical metrics are precise continuous variables that cover the intensity spectrum, while translational metrics facilitate meaningful, public-health messages and can be described in terms of activities (e.g. brisk walking) or intensity (e.g. moderate-to-vigorous physical activity). Two analytical metrics that capture the volume and intensity of the 24-h activity profile are average acceleration (volume) and intensity gradient (intensity distribution). These allow investigation of independent, additive and interactive associations of volume and intensity of activity with health; however, they are not immediately interpretable. The MX metrics, the acceleration above which the most active X minutes are accumulated, are translational metrics that can be interpreted in terms of indicative activities. Using a range of MX metrics illustrates the intensity gradient and average acceleration (i.e. 24-h activity profile). The M120, M60, M30, M15 and M5 illustrate the most active accumulated minutes of the day, the M1/3DAY the most active accumulated 8 h of the day. We demonstrate how radar plots of MX metrics can be used to interpret and translate results from between- and within-group comparisons, provide information on meeting guidelines, assess individual activity profiles relative to percentiles and compare activity profiles between domains and/or time periods.

30 March 2021 in The Journal of Nutrition
Verified
Journal Article
Open access
PDF file
SAStavroula Argyridou
Stavroula Argyridou
MDMelanie J Davies
Melanie J Davies
GBGregory J H Biddle
Gregory J H Biddle
DBDennis Bernieh
Dennis Bernieh
TSToru Suzuki
Toru Suzuki
ASAlice C Smith
Alice C Smith
Trimethylamine N-oxide (TMAO), a metabolite generated by the gut in response (in part) to meat consumption, is linked to poor cardiometabolic health. We investigate the effect of an 8-week vegan diet, followed by a 4-week period of unrestricted diet, on glucose tolerance and plasma TMAO in human omnivores with obesity or dysglycemia. This interventional single-group prospective trial involved 23 regular meat eaters with dysglycemia [glycated hemoglobin ≥ 5.7% and ≤8% (39–64 mmol/mol)], or obesity (ΒΜΙ ≥ 30 kg/m2) aged 57.8 ± 10.0 years. Participants [14 men (60.9%) and 9 women (39.1%)] were supported in following a vegan diet for 8 weeks, followed by 4 weeks of unrestricted diet. The primary outcomes (plasma TMAO and glucose) were assessed at baseline, during the vegan diet (weeks 1 and 8), and after the unrestricted diet period (week 12). TMAO was assessed after fasting and glucose was measured as a time-averaged total AUC using a 180-minute oral-glucose-tolerance test. Generalized estimating equation models with an exchangeable correlation structure were used to assess changes from baseline, adjusting for age, sex, ethnicity, and weight. TMAO levels (marginal mean) were reduced after weeks 1 and 8 of a vegan diet compared to baseline, from 10.7 (97.5% CI, 6.61–17.3) μmol/L to 5.66 (97.5% CI, 4.56–7.02) μmol/L and 6.38 (97.5% CI, 5.25–7.74) μmol/L, respectively; however, levels rebounded at week 12 after resumption of an unrestricted diet (17.5 μmol/L; 97.5% CI, 7.98–38.4). Postprandial glucose levels (marginal means) were reduced after weeks 1 and 8 compared to baseline, from 8.07 (97.5% CI, 7.24–8.90) mmol/L to 7.14 (97.5% CI, 6.30–7.98) mmol/L and 7.34 (97.5% CI, 6.63–8.04) mmol/L, respectively. Results for glucose and TMAO were independent of weight loss. Improvements in the lipid profile and markers of renal function were observed at week 8. These findings suggest that a vegan diet is an effective strategy for improving glucose tolerance and reducing plasma TMAO in individuals with dysglycemia or obesity. This study was registered at clinicaltrials.gov as NCT03315988.

1 January 2021 in Mayo Clinic Proceedings
Verified
Journal Article
Closed access
ARAlex Rowlands
Alex Rowlands
DKDavid E. Kloecker
David E. Kloecker
YCYogini Chudasama
Yogini Chudasama
MDMelanie J Davies
Melanie J Davies
NDNathan Dawkins
Nathan Dawkins
TYThomas Yates
Thomas Yates

2 October 2022 in Journal of Sports Sciences
Verified
Journal Article
Open access
ARAlex Rowlands
Alex Rowlands
BMBen David Maylor
Ben David Maylor
NDNathan Dawkins
Nathan Dawkins
PDPaddy C Dempsey
Paddy C Dempsey
CECharlotte Edwardson
Charlotte Edwardson
TYThomas Yates
Thomas Yates
The Verisense Step Count Algorithm facilitates generation of steps from wrist-worn accelerometers. Based on preliminary evidence suggesting a proportional bias with overestimation at low steps/day, but underestimation at high steps/day, the algorithm parameters have been revised. We aimed to establish validity of the original and revised algorithms relative to waist-worn ActiGraph step cadence. We also assessed whether step cadence was similar across accelerometer brand and wrist. Ninety-eight participants (age: 58.6±11.1 y) undertook six walks (~500 m hard path) at different speeds (cadence: 92.9±9.5–127.9±8.7 steps/min) while wearing three accelerometers on each wrist (Axivity, GENEActiv, ActiGraph) and an ActiGraph on the waist. Of these, 24 participants also undertook one run (~1000 m). Mean bias for the original algorithm was −21 to −26.1 steps/min (95% limits of agreement (LoA) ~±65 steps/min) and mean absolute percentage error (MAPE) 17–22%. This was unevenly distributed with increasing error as speed increased. Mean bias and 95%LoA were halved with the revised algorithm parameters (~-10 to −12 steps/min, 95%LoA ~30 steps/min, MAPE ~10-12%). Performance was similar across brand and wrist. The revised step algorithm provides a more valid measure of step cadence than the original, with MAPE similar to recently reported wrist-wear summary MAPE (7–11%).

22 May 2020 in Medicine & Science in Sports & Exercise
Verified
Journal Article
Closed access
ARAlex Rowlands
Alex Rowlands
CECharlotte L. Edwardson
Charlotte L. Edwardson
NDNathan Dawkins
Nathan Dawkins
BMBEN D. Maylor
BEN D. Maylor
KMKristen M. Metcalf
Kristen M. Metcalf
KJKathleen F. Janz
Kathleen F. Janz
Purpose: High-impact physical activity is associated with bone health, but higher volumes of lower-intensity activity may also be important. The aims of this study were to: 1) investigate the relative importance of volume and intensity of physical activity accumulated during late adolescence for bone health at age 23 yr; and 2) illustrate interpretation of the results. Methods: This is a secondary analysis of data from the Iowa Bone Development Study, a longitudinal study of bone health from childhood through to young adulthood. The volume (average acceleration) and intensity distribution (intensity gradient) of activity at age 17, 19, 21, and 23 yr were calculated from raw acceleration ActiGraph data and averaged across ages. Hip areal bone mineral density (aBMD), total body bone mineral content (BMC), spine aBMD, and hip structural geometry (dual-energy X-ray absorptiometry, Hologic QDR4500A) were assessed at age 23 yr. Valid data, available for 220 participants (124 girls), were analyzed with multiple regression. To elucidate significant effects, we predicted bone outcomes when activity volume and intensity were high (+1SD), medium (mean), and low (−1SD). Results: There were additive associations of volume and intensity with hip aBMD and total body BMC (low-intensity/low-volume cf. high-intensity/high-volume = ∆0.082 g·cm−2 and ∆169.8 g, respectively). For males only, spine aBMD intensity was associated independently of volume (low-intensity cf. high-intensity = ∆0.049 g·cm−2). For hip structural geometry, volume was associated independently of intensity (low-volume cf. high-volume = ∆4.8–6.6%). Conclusions: The activity profile associated with optimal bone outcomes was high in intensity and volume. The variation in bone health across the activity volume and intensity distribution suggests intensity is key for aBMD and BMC, whereas high volumes of lower intensity activity may be beneficial for hip structural geometry.